rxstat › Shortages › Apremilast

Apremilast shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Apremilast is in a widespread shortage in Canada. 2 of 3 reported products are affected. Manufacturers have not committed to a recovery date.
Products affected
2 of 3
In shortage since
Dec 9, 2025
Reports on file
4
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-APREMILAST
30MG · TABLET · APOTEX INC
DIN 02538180 · since May 5, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
GLN-APREMILAST
30MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02518910 · since Dec 9, 2025, no end estimate · Disruption of the manufacture of the drug.
Resolved
APO-APREMILAST
30MG · TABLET · APOTEX INC
DIN 02538180 · ended Jan 30, 2025 · Disruption of the manufacture of the drug.
Resolved
AURO-APREMILAST
30MG · TABLET · AURO PHARMA INC
DIN 02524104 · ended Aug 28, 2024 · Demand increase for the drug.

What's happening

Apremilast is currently affected by 2 active shortage reports filed with Health Canada by APOTEX INC, GLENMARK PHARMACEUTICALS CANADA INC..

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Apremilast is classified under “IMMUNOSUPPRESSANTS” (ATC L04AA).

Recent changes

Common questions

When will Apremilast be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Apremilast in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (immunosuppressants)

Partial shortageAdalimumab1 of 7 reported products affectedPartial shortageApremilast Apremilast Apremilast1 of 1 reported products affected · est. return Aug 28, 2026Partial shortageBasiliximab1 of 1 reported products affectedPartial shortageCyclosporine1 of 8 reported products affected · est. return Jul 30, 2027Partial shortageFingolimod3 of 8 reported products affectedPartial shortageLeflunomide3 of 15 reported products affected · est. return Jul 24, 2026

All immunosuppressants shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.